Immediate Impact
1 by Nobel laureates 58 standout
Citing Papers
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis
2024 Standout
Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial
2024 Standout
Works of Shinn‐Chern Chen being referenced
Risk stratification of non-alcoholic fatty liver disease across body mass index in a community basis
2019
Cytokeratin-18 and uric acid predicts disease severity in Taiwanese nonalcoholic steatohepatitis patients
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Shinn‐Chern Chen | 661 | 602 | 63 | 148 | 38 | 815 | |
| Jeng‐Fu Yang | 792 | 672 | 75 | 156 | 41 | 971 | |
| Jesús Castillo | 504 | 481 | 102 | 126 | 26 | 840 | |
| A. Gila | 628 | 608 | 61 | 140 | 26 | 862 | |
| Mahmoud Khattab | 615 | 587 | 43 | 76 | 34 | 765 | |
| Ching‐I Huang | 727 | 643 | 71 | 110 | 87 | 929 | |
| Tsuyoshi Todo | 662 | 482 | 185 | 190 | 29 | 886 | |
| Daniela Villari | 370 | 323 | 83 | 89 | 42 | 734 | |
| Ilaria Serio | 544 | 351 | 77 | 185 | 21 | 716 | |
| Kazuyuki Ohata | 531 | 376 | 121 | 101 | 16 | 752 | |
| Francesco Picciotto | 458 | 489 | 182 | 55 | 35 | 840 |
All Works
Loading papers...